Larry L Luchsinger
Overview
Explore the profile of Larry L Luchsinger including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
895
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Insights into highly engraftable hematopoietic cells from 27-year cryopreserved umbilical cord blood
Broxmeyer H, Luchsinger L, Weinberg R, Jimenez A, Frenet E, Vant Hof W, et al.
Cell Rep Med
. 2023 Nov;
4(11):101259.
PMID: 37913777
Umbilical cord blood transplantation is a life-saving treatment for malignant and non-malignant hematologic disorders. It remains unclear how long cryopreserved units remain functional, and the length of cryopreservation is often...
2.
Shi P, Luchsinger L, Greally J, Delaney C
Curr Opin Hematol
. 2022 Sep;
29(6):317-326.
PMID: 36066376
Purpose Of Review: The purpose of this review is to primarily discuss the unwarranted decline in the use of umbilical cord blood (UCB) as a source of donor hematopoietic stem...
3.
Haynes W, Kamath K, Bozekowski J, Baum-Jones E, Campbell M, Casanovas-Massana A, et al.
Commun Biol
. 2021 Nov;
4(1):1317.
PMID: 34811480
As Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) continues to spread, characterization of its antibody epitopes, emerging strains, related coronaviruses, and even the human proteome in naturally infected patients can...
4.
Nesbitt D, Jin D, Hogan J, Yang J, Chen H, Chan P, et al.
BMC Infect Dis
. 2021 Aug;
21(1):871.
PMID: 34433423
Background: Epidemic projections and public health policies addressing Coronavirus disease (COVID)-19 have been implemented without data reporting on the seroconversion of the population since scalable antibody testing has only recently...
5.
Luchsinger L
Curr Opin Hematol
. 2021 Jul;
28(6):417-423.
PMID: 34232142
Purpose Of Review: Hematopoietic stem cells (HSCs) possess the ability to regenerate over a lifetime in the face of extreme cellular proliferation and environmental stress. Yet, mechanisms that control the...
6.
Jin D, Nesbitt D, Yang J, Chen H, Horowitz J, Jones M, et al.
PLoS One
. 2021 Apr;
16(4):e0250319.
PMID: 33909646
Projections of the stage of the Severe Acute Respiratory Syndrome-Coronavirus-2 (SARS-CoV-2) pandemic and local, regional and national public health policies to limit coronavirus spread as well as "reopen" cities and...
7.
Fidler T, Xue C, Yalcinkaya M, Hardaway B, Abramowicz S, Xiao T, et al.
Nature
. 2021 Mar;
592(7853):296-301.
PMID: 33731931
Clonal haematopoiesis, which is highly prevalent in older individuals, arises from somatic mutations that endow a proliferative advantage to haematopoietic cells. Clonal haematopoiesis increases the risk of myocardial infarction and...
8.
9.
Luchsinger L, Ransegnola B, Jin D, Muecksch F, Weisblum Y, Bao W, et al.
J Clin Microbiol
. 2020 Sep;
58(12).
PMID: 32917729
The development of neutralizing antibodies (NAbs) against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) following infection or vaccination is likely to be critical for the development of sufficient population immunity...
10.
Ragnesola B, Jin D, Lamb C, Shaz B, Hillyer C, Luchsinger L
BMC Res Notes
. 2020 Aug;
13(1):372.
PMID: 32762746
Objective: COVID19 has caused a global and ongoing pandemic. The need for population seroconversion data is apparent to monitor and respond to the pandemic. Using a lateral flow assay (LFA)...